Stock Market Regulatory conditions on Novo Holdings’ $16.5 billion Catalent deal fulfilled, companies say By ReutersDecember 23, 20240 (Reuters) – Novo Holdings’ $16.5 billion acquisition of U.S. contract drug maker Catalent is set to be completed in the…
Stock Market Roche comes out against allowing takeover of drug manufacturer Catalent By ReutersNovember 6, 20240 By Ludwig Burger FRANKFURT (Reuters) – The CEO of Roche, a pharmaceutical giant, has expressed concerns about the potential takeover…
Stock Market Catalent delays filing of annual report By ReutersSeptember 4, 20240 (Reuters) – Catalent (NYSE:) announced on Friday that it was unable to meet the deadline for filing its annual report…
